Basic Information
RNALocate ID: | RLID:01001743 |
RNA Symbol: | hsa-miR-30b-5p |
Localization: | Plasma membrane vesicle |
RNA Information
RNA Name: | hsa-miR-30b |
RNA ID: | miRBase:MIMAT0000420 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 27165101 |
Tissue/Cell Line: | Ad293 cells |
Method: | qRT-PCR |
Quantitative analyses of representative mRNA (CD81, eEF2 and POLR2C) and microRNA (hsa-let-7d* and hsa-miR-30b) in PMVs and Ad293 cells were shown. Originally published in Biomed Microdevices. Lin HP, et al, 2016. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | Real-time RT-PCR was carried out to investigate whether mRNA and microRNA existed in PMVs. As typical representatives, the transcripts of membrane protein CD81, nucleus protein POLR2C, and cytosolic protein eEF2 were detected at levels comparable to that in Ad293 cells (Fig. 2c). Similarly, transcript levels of microRNAs, hsa-let-7d* and hsa-miR-30b, were found to be maintained in PMVs as compared to that in Ad293 cells (Fig. 2c). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001739 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001740 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001741 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001742 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11001694 | Exosome | Human milk | 28688106 |
RLID:11001695 | Exosome | Plasma | 30154547 |
RLID:11001696 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11001697 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001698 | Exosome | Breast milk | 22211110 |
RLID:11001699 | Exosome | Brain tissue | 23382797 |
RLID:11001700 | Exosome | Plasma | 23663360 |
RLID:11001701 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001702 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11001703 | Microvesicle | Seminal plasma | 23539611 |
RLID:11001704 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000073 | Exosome | B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Tongue tissue | |
RLID-D:11000348 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-30b-5p | Splenic marginal zone lymphoma | MNDR-E-MI-36938 |
MNDR | hsa-miR-30b-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-36939 |
MNDR | hsa-miR-30b-5p | Glomerulosclerosis | MNDR-E-MI-36940 |
MNDR | hsa-miR-30b-5p | Oral squamous cell carcinoma | MNDR-E-MI-36941 |
MNDR | hsa-miR-30b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-36942 |
MNDR | hsa-miR-30b-5p | Medulloblastoma | MNDR-E-MI-36943 |
MNDR | hsa-miR-30b-5p | B cell lymphoma of malt type | MNDR-E-MI-36944 |
MNDR | hsa-miR-30b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-36945 |
MNDR | hsa-miR-30b-5p | Lymphoma | MNDR-E-MI-36946 |
MNDR | hsa-miR-30b-5p | Lymphoma non-hodgkin | MNDR-E-MI-36947 |
MNDR | hsa-miR-30b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-36948 |
MNDR | hsa-miR-30b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-36949 |
MNDR | hsa-miR-30b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-36950 |
MNDR | hsa-miR-30b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-36951 |
MNDR | hsa-miR-30b-5p | Her2-receptor positive breast cancer | MNDR-E-MI-36952 |
MNDR | hsa-miR-30b-5p | Niemann-pick disease type c | MNDR-E-MI-36953 |
MNDR | hsa-miR-30b-5p | Dermatomyositis | MNDR-E-MI-36954 |
MNDR | hsa-miR-30b-5p | Prostate cancer | MNDR-E-MI-36955 |
MNDR | hsa-miR-30b-5p | Gastric cancer | MNDR-E-MI-36956 |
MNDR | hsa-miR-30b-5p | Gastric lymphoma | MNDR-E-MI-36957 |
MNDR | hsa-miR-30b-5p | Alzheimer disease | MNDR-E-MI-36958 |
MNDR | hsa-miR-30b-5p | Hypertension | MNDR-E-MI-36959 |
MNDR | hsa-miR-30b-5p | Intracranial aneurysm | MNDR-E-MI-36960 |
MNDR | hsa-miR-30b-5p | Esophageal carcinoma | MNDR-E-MI-36961 |
MNDR | hsa-miR-30b-5p | Dysautonomia familial | MNDR-E-MI-36962 |
MNDR | hsa-miR-30b-5p | Myotonic dystrophy | MNDR-E-MI-36963 |
MNDR | hsa-miR-30b-5p | Muscular dystrophy duchenne | MNDR-E-MI-36964 |
MNDR | hsa-miR-30b-5p | Seizures | MNDR-E-MI-36965 |
MNDR | hsa-miR-30b-5p | Head and neck cancer | MNDR-E-MI-36966 |
MNDR | hsa-miR-30b-5p | Leukemia | MNDR-E-MI-36967 |
MNDR | hsa-miR-30b-5p | Huntington disease | MNDR-E-MI-36968 |
MNDR | hsa-miR-30b-5p | Chorea | MNDR-E-MI-36969 |
MNDR | hsa-miR-30b-5p | Cardiovascular disease | MNDR-E-MI-36970 |
MNDR | hsa-miR-30b-5p | Lung cancer | MNDR-E-MI-36971 |
MNDR | hsa-miR-30b-5p | Down syndrome | MNDR-E-MI-36972 |
MNDR | hsa-miR-30b-5p | Parkinson disease | MNDR-E-MI-36973 |
MNDR | hsa-miR-30b-5p | Niemann-pick disease | MNDR-E-MI-36974 |
MNDR | hsa-miR-30b-5p | Breast cancer | MNDR-E-MI-36975 |
MNDR | hsa-miR-30b-5p | Pituitary neoplasms | MNDR-E-MI-36976 |
MNDR | hsa-miR-30b-5p | Pancreatic cancer | MNDR-E-MI-36977 |
MNDR | hsa-miR-30b-5p | Melanoma | MNDR-E-MI-36978 |
MNDR | hsa-miR-30b-5p | Rectum adenocarcinoma | MNDR-E-MI-36979 |
MNDR | hsa-miR-30b-5p | Nephroblastoma | MNDR-E-MI-36980 |
MNDR | hsa-miR-30b-5p | Colon cancer | MNDR-E-MI-36981 |
MNDR | hsa-miR-30b-5p | Colon adenocarcinoma | MNDR-E-MI-36982 |
MNDR | hsa-miR-30b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-36983 |
MNDR | hsa-miR-30b-5p | Ovarian cancer | MNDR-E-MI-36984 |
MNDR | hsa-miR-30b-5p | Acromegaly | MNDR-E-MI-36985 |
MNDR | hsa-miR-30b-5p | Prostate adenocarcinoma | MNDR-E-MI-36986 |
MNDR | hsa-miR-30b-5p | Carcinoma ductal breast | MNDR-E-MI-36987 |
MNDR | hsa-miR-30b-5p | Glioblastoma | MNDR-E-MI-36988 |
MNDR | hsa-miR-30b-5p | Glioma | MNDR-E-MI-36989 |
MNDR | hsa-miR-30b-5p | Nemaline myopathy | MNDR-E-MI-36990 |
MNDR | hsa-miR-30b-5p | Central nervous system lymphoma | MNDR-E-MI-36991 |
MNDR | hsa-miR-30b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-36992 |
MNDR | hsa-miR-30b-5p | Temporal lobe epilepsy | MNDR-E-MI-36993 |
MNDR | hsa-miR-30b-5p | Inclusion body myositis | MNDR-E-MI-36994 |
MNDR | hsa-miR-30b-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-36995 |
MNDR | hsa-miR-30b-5p | Gastric adenocarcinoma | MNDR-E-MI-36996 |
MNDR | hsa-miR-30b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-36997 |
MNDR | hsa-miR-30b-5p | Pituitary adenoma | MNDR-E-MI-36998 |
MNDR | hsa-miR-30b-5p | Lung squamous cell carcinoma | MNDR-E-MI-36999 |
MNDR | hsa-miR-30b-5p | Carcinoma lung non-small-cell | MNDR-E-MI-37000 |
MNDR | hsa-miR-30b-5p | Lung adenocarcinoma | MNDR-E-MI-37001 |
MNDR | hsa-miR-30b-5p | Thyroid carcinoma | MNDR-E-MI-37002 |
MNDR | hsa-miR-30b-5p | Bladder urothelial carcinoma | MNDR-E-MI-37003 |
MNDR | hsa-miR-30b-5p | Pancreatic adenocarcinoma | MNDR-E-MI-37004 |
MNDR | hsa-miR-30b-5p | Carcinoma renal cell | MNDR-E-MI-37005 |
MNDR | hsa-miR-30b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-37006 |
MNDR | hsa-miR-30b-5p | Clear cell renal cell carcinoma | MNDR-E-MI-37007 |
MNDR | hsa-miR-30b-5p | Cholangiocarcinoma | MNDR-E-MI-37008 |
MNDR | hsa-miR-30b-5p | Esophageal cancer | MNDR-E-MI-37009 |
MNDR | hsa-miR-30b-5p | Liver cirrhosis | MNDR-E-MI-37010 |
MNDR | hsa-miR-30b-5p | Lung small cell carcinoma | MNDR-E-MI-37011 |
MNDR | hsa-miR-30b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-37012 |
MNDR | hsa-miR-30b-5p | T acute lymphoblastic leukemia | MNDR-E-MI-37013 |
MNDR | hsa-miR-30b-5p | Acute t cell leukemia | MNDR-E-MI-37014 |
MNDR | hsa-miR-30b-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-37015 |
MNDR | hsa-miR-30b-5p | Fibromyalgia | MNDR-E-MI-37016 |
MNDR | hsa-miR-30b-5p | Breast invasive carcinoma | MNDR-E-MI-37017 |
MNDR | hsa-miR-30b-5p | Hepatocellular carcinoma | MNDR-E-MI-37018 |
MNDR | hsa-miR-30b-5p | B-cell lymphoma | MNDR-E-MI-37019 |
MNDR | hsa-miR-30b-5p | Rheumatoid arthritis | MNDR-E-MI-37020 |
MNDR | hsa-miR-30b-5p | T-cell leukemia | MNDR-E-MI-37021 |
MNDR | hsa-miR-30b-5p | Retinoblastoma | MNDR-E-MI-37022 |
MNDR | hsa-miR-30b-5p | Barrett's adenocarcinoma | MNDR-E-MI-37023 |
MNDR | hsa-miR-30b-5p | Hodgkin lymphoma | MNDR-E-MI-37024 |
MNDR | hsa-miR-30b-5p | Burkitt lymphoma | MNDR-E-MI-37025 |
MNDR | hsa-miR-30b-5p | Tonsil cancer | MNDR-E-MI-37026 |
MNDR | hsa-miR-30b-5p | Neuromyelitis optica | MNDR-E-MI-37027 |
MNDR | hsa-miR-30b-5p | Acute myelogenous leukemia | MNDR-E-MI-37028 |
MNDR | hsa-miR-30b-5p | Colorectal cancer | MNDR-E-MI-37029 |
MNDR | hsa-miR-30b-5p | Nasopharynx carcinoma | MNDR-E-MI-37030 |
MNDR | hsa-miR-30b-5p | Ependymoma | MNDR-E-MI-37031 |
MNDR | hsa-miR-30b-5p | Cardiomegaly | MNDR-E-MI-37032 |
MNDR | hsa-miR-30b-5p | Nasopharyngeal cancer | MNDR-E-MI-37033 |
MNDR | hsa-miR-30b-5p | Epstein-barr virus infections | MNDR-E-MI-37034 |
MNDR | hsa-miR-30b-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-37035 |
MNDR | hsa-miR-30b-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-37036 |
MNDR | hsa-miR-30b-5p | Brain injury chronic | MNDR-E-MI-37037 |
MNDR | hsa-miR-30b-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-37038 |
MNDR | hsa-miR-30b-5p | Stroke | MNDR-E-MI-37039 |
MNDR | hsa-miR-30b-5p | Stroke lacunar | MNDR-E-MI-37040 |
MNDR | hsa-miR-30b-5p | Barrett's carcinogenesis | MNDR-E-MI-37041 |
MNDR | hsa-miR-30b-5p | Duke C | MNDR-E-MI-37042 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AC254633.1 | Homo sapiens | RR00032111 |
TOP